Learn more

UNIV NAT CORP KOCHI UNIV

Overview
  • Total Patents
    36
  • GoodIP Patent Rank
    50,975
  • Filing trend
    ⇧ 700.0%
About

UNIV NAT CORP KOCHI UNIV has a total of 36 patent applications. It increased the IP activity by 700.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SINGAPORE HEALTH SERV PTE LTD, FUJITA GAKUEN and UMC UTRECHT HOLDING BV.

Patent filings per year

Chart showing UNIV NAT CORP KOCHI UNIVs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Naka Tetsuji 8
#2 Serada Satoshi 8
#3 Fujimoto Minoru 8
#4 Sato Takayuki 7
#5 Taniuchi Keisuke 6
#6 Toyoura Masayoshi 5
#7 Shoya Yuji 5
#8 Fukushima Atsuki 3
#9 Uchiyama Jumpei 3
#10 Daibata Masanori 3

Latest patents

Publication Filing date Title
WO2021080020A1 Nucleic acid delivery enhancer
WO2021075575A1 Method for predicting nuclear magnetic resonance chemical shift values, prediction apparatus, and prediction program
WO2021039909A1 Method for enhancing luminous intensity of fluorescent dye
WO2021033431A1 Openable and closable clip
WO2021006113A1 Medical tool for fingertip
WO2020129705A1 Wastewater treatment apparatus and wastewater treatment method
WO2020129707A1 Wastewater treatment apparatus and wastewater treatment method
WO2020050272A1 Diagnosis support device, diagnosis support method and diagnosis support program
US2021038152A1 Method for diagnosing cerebrospinal fluid hypovolemia
WO2020027002A1 Method for producing seaweed cells
WO2019203342A1 Separating device, separating method, ri separation and purification system, and ri separation and purification method
WO2019176729A1 Novel bacteriophage and treatment agent for bacterial endophthalmitis
WO2019131136A1 Brain protective agent
WO2019021654A1 Marker for prognosis of pancreatic cancer, kit for diagnosing prognosis of pancreatic cancer, and method for predicting prognosis of pancreatic cancer
US2020308299A1 Anti-gpc-1 antibody
WO2018199205A1 Feed for aquatic animals
WO2018034326A1 Magnetic resonance device and method
AU2016367349A1 Marker for pancreatic cancer and intraductal papillary mucinous neoplasms
US2018050119A1 Method for specifying leakage part of cerebrospinal fluid in cerebrospinal fluid hypovolemia patient, and method for treating cerebrospinal fluid hypovolemia
EP3088001A1 Anti-lipolysis stimulated liporotein receptor antibodies for treatment of ovarian cancer